These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 31598635

  • 21. Upregulated microRNA-214 enhances cardiac injury by targeting ITCH during coxsackievirus infection.
    Chen ZG, Liu H, Zhang JB, Zhang SL, Zhao LH, Liang WQ.
    Mol Med Rep; 2015 Jul; 12(1):1258-64. PubMed ID: 25815880
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis.
    Saraste A, Arola A, Vuorinen T, Kytö V, Kallajoki M, Pulkki K, Voipio-Pulkki LM, Hyypiä T.
    Cardiovasc Pathol; 2003 Jul; 12(5):255-62. PubMed ID: 14507574
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The protection effects of survivin in the cell model of CVB3-induced viral myocarditis.
    Wu R, Wu T, Li P, Wang Q, Shi Y, Zhan Y, Zhang S, Xia T, Wang Z, Lv H.
    Heart Vessels; 2020 Aug; 35(8):1171-1179. PubMed ID: 32328712
    [Abstract] [Full Text] [Related]

  • 26. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3.
    Knowlton KU, Jeon ES, Berkley N, Wessely R, Huber S.
    J Virol; 1996 Nov; 70(11):7811-8. PubMed ID: 8892902
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice.
    Gao G, Zhang J, Si X, Wong J, Cheung C, McManus B, Luo H.
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H401-8. PubMed ID: 18515649
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. CX3CR1 knockout aggravates Coxsackievirus B3-induced myocarditis.
    Müller I, Pappritz K, Savvatis K, Puhl K, Dong F, El-Shafeey M, Hamdani N, Hamann I, Noutsias M, Infante-Duarte C, Linke WA, Van Linthout S, Tschöpe C.
    PLoS One; 2017 Jul; 12(8):e0182643. PubMed ID: 28800592
    [Abstract] [Full Text] [Related]

  • 33. MCPIP1 inhibits coxsackievirus B3 replication by targeting viral RNA and negatively regulates virus-induced inflammation.
    Li M, Yan K, Wei L, Yang Y, Qian Q, Xu W.
    Med Microbiol Immunol; 2018 Feb; 207(1):27-38. PubMed ID: 29043433
    [Abstract] [Full Text] [Related]

  • 34. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis.
    Li K, Xu W, Guo Q, Jiang Z, Wang P, Yue Y, Xiong S.
    Circ Res; 2009 Aug 14; 105(4):353-64. PubMed ID: 19608981
    [Abstract] [Full Text] [Related]

  • 35. FTY720 alleviates coxsackievirus B3-induced myocarditis and inhibits viral replication through regulating sphingosine 1-phosphate receptors and AKT/caspase-3 pathways.
    Wang X, Li M, Yu Y, Liu G, Yu Y, Zou Y, Ge J, Chen R.
    J Cell Physiol; 2019 Aug 14; 234(10):18029-18040. PubMed ID: 30843214
    [Abstract] [Full Text] [Related]

  • 36. Coxsackievirus B3 engineered to contain microRNA targets for muscle-specific microRNAs displays attenuated cardiotropic virulence in mice.
    He F, Yao H, Wang J, Xiao Z, Xin L, Liu Z, Ma X, Sun J, Jin Q, Liu Z.
    J Virol; 2015 Jan 15; 89(2):908-16. PubMed ID: 25339771
    [Abstract] [Full Text] [Related]

  • 37. Characterization of a murine model of myocarditis induced by a reactivated coxsackievirus B3.
    Zhang H, Yousef GE, Ouyang X, Archard LC.
    Int J Exp Pathol; 1994 Apr 15; 75(2):99-110. PubMed ID: 8199011
    [Abstract] [Full Text] [Related]

  • 38. Virus-host coevolution in a persistently coxsackievirus B3-infected cardiomyocyte cell line.
    Pinkert S, Klingel K, Lindig V, Dörner A, Zeichhardt H, Spiller OB, Fechner H.
    J Virol; 2011 Dec 15; 85(24):13409-19. PubMed ID: 21976640
    [Abstract] [Full Text] [Related]

  • 39. Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.
    Slifka MK, Pagarigan R, Mena I, Feuer R, Whitton JL.
    J Virol; 2001 Mar 15; 75(5):2377-87. PubMed ID: 11160741
    [Abstract] [Full Text] [Related]

  • 40. MicroRNA-22-3p displaces critical host factors from the 5' UTR and inhibits the translation of Coxsackievirus B3 RNA.
    Rani P, George B, V S, Biswas S, V M, Pal A, Rajmani RS, Das S.
    J Virol; 2024 Feb 20; 98(2):e0150423. PubMed ID: 38289119
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.